Company page

Vericel Corporation

Vericel Corporation, trading under the ticker VCEL, is a public company based in the United States with a market capitalization of approximately $2.05 billion. The company focuses on developing and commercializing advanced cell therapies for patients with serious diseases and conditions. Vericel aims to improve patient outcomes through innovative medical solutions.